Abstract:Muscle wasting is often associated with chronic inflammation. Because tumor necrosis factor ␣ (TNF-␣) has been implicated as a major mediator of cachexia, its effects on C2C12 myocytes were examined. TNF-␣ activated nuclear factor-␬B (NF-␬B) and interfered with the expression of muscle proteins in differentiating myoblasts. Introduction of a mutant form of inhibitory protein ␬B␣ (I␬B␣) restored myo-genic differentiation in myoblasts treated with TNF-␣ or interleukin 1␤. Conversely, activation of NF-␬B by overexpression of I␬B kinase was sufficient to block myogenesis, illustrating the causal link between NF-␬B activation and inhibition of myogenic differentiation. The inhibitory effects of TNF-␣ on myogenic differentiation were reversible, indicating that the effects of the cytokine were not due to nonspecific toxicity. Treatment of differentiated myotubes with TNF-␣ did not result in a striking loss of muscle-specific proteins, which shows that myogenesis was selectively affected in the myoblast stage by TNF-␣. An important finding was that NF-␬B was activated to the same extent in differentiating and differentiated cells, illustrating that once myocytes have differentiated they become refractory to the effects of NF-␬B activation. These results demonstrate that inflammatory cytokines may contribute to muscle wasting through the inhibition of myogenic differentiation via a NF-␬B-dependent pathway.—Lan-matory cytokines inhibit myogenic differentiation through activation of nuclear factor-␬B. Muscle wasting, defined as the loss of skeletal muscle tissue, commonly occurs in chronic wasting syndromes, such as AIDS (1), cancer (2), chronic heart failure (3), and chronic obstructive pulmonary disease (4 – 6), and is an independent predictor of mortality. Remarkably, in many of these conditions muscle wasting is associated with chronic elevations in circulating inflamma-tory cytokines, in particular tumor necrosis factor ␣ (TNF-␣) (7–10). Muscle wasting is generally believed to result from disturbances in the energy or anabolism-catabolism balance. For example, imbalances in myofi-brillar protein synthesis and proteolysis have been demonstrated in experimental models of cancer ca-chexia (11, 12) and sepsis (13). Elevated levels of circulating inflammatory mediators, such as TNF-␣ and interleukin 1 (IL-1), were believed to trigger the events leading to muscle wasting in these models. In support of this, chronic administration of TNF-␣ or IL-1 induced weight loss and skeletal muscle wasting in rats (14). Muscle wasting may alternatively result from a decrease of the number of fibers. In support of this proposal, an increased prevalence of apoptotic myonu-clei has been associated with the loss of skeletal muscle tissue in muscular dystrophies and inflammatory myop-athies (15–17). In addition, …

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies

Integrative Analysis of MicroRNA and Mrna Data Reveals an Orchestrated Function of MicroRNAs in Skeletal Myocyte Differentiation in Response to TNF-α or IGF1

Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b

The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy

Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies

Deficiency of muscle-generated brain-derived neurotrophic factor causes inflammatory myopathy through reactive oxygen species-mediated necroptosis and pyroptosis

Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy

miR-30 Family microRNAs Regulate Myogenic Differentiation and Provide Negative Feedback on the microRNA Pathway

Genomic Signatures Characterize Leukocyte Infiltration in Myositis Muscles

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

IL-17 signaling pathway: A potential therapeutic target for reducing skeletal muscle inflammation

Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations

A Combined Genome-Wide Dna Methylation and Mrna Expression Analysis Identified Aberrant Gene Regulatory Pathways in Inflammatory Myositis

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis

Mitochondrial mechanisms in the pathogenesis of chronic inflammatory musculoskeletal disorders

Characterization of Undiscovered miRNA Involved in Tumor Necrosis Factor Alpha-Induced Atrophy in Mouse Skeletal Muscle Cell Line

Roles of mast cells in the pathogenesis of inflammatory myopathy

TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach

Activation of the Ubiquitin Proteasome Pathway in a Mouse Model of Inflammatory Myopathy: A Potential Therapeutic Target